GI Innovation, Inc. (KOSDAQ:358570)
6,620.00
-500.00 (-7.02%)
Nov 20, 2026, 3:30 PM KST
GI Innovation Market Cap
GI Innovation has a market cap or net worth of 427.1 billion as of November 20, 2026. It is the 16,919th most valuable company in the world and the 458th biggest in South Korea. Its market cap has decreased by 63.59% in one year.
Market Cap
427.10B
Enterprise Value
389.78B
Revenue
5.50B
Global Rank
Country Rank
#458 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 30, 2023, GI Innovation's market cap has decreased from 445.59B to 427.10B, a decrease of -4.15%. That is a compound annual growth rate of -1.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 427.10B | -62.08% |
| Dec 30, 2025 | 1.13T | 187.90% |
| Dec 30, 2024 | 391.21B | -26.45% |
| Dec 28, 2023 | 531.89B | 19.37% |
| Mar 30, 2023 | 445.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 676.19B |
| Proteina | 645.56B |
| Komipharm International | 598.76B |
| Hyundai Bioscience | 585.78B |
| Pharmicell | 469.23B |
| AbClon | 465.88B |
| Onconic Therapeutics | 463.61B |
| Medy-Tox | 446.91B |